Search Results

Displaying Results 7826-7850 of 28367 "'B'"

Jun 29, 2026, 04:19 ET SES AI Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SES

SES) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of

More news about: DJS Law Group LLP


Jun 29, 2026, 03:52 ET BRCB Investors Have Opportunity to Lead Black Rock Coffee Bar, Inc. Securities Fraud Lawsuit with the Schall Law Firm

BRCB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:50 ET EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm

EMBC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:46 ET BTU Investors Have Opportunity to Lead Peabody Energy Corporation Securities Fraud Lawsuit with the Schall Law Firm

BTU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:41 ET Futu Holdings Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FUTU

FUTU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of

More news about: DJS Law Group LLP


Jun 29, 2026, 03:41 ET FUTU Investors Have Opportunity to Lead Futu Holdings Limited Securities Fraud Lawsuit with the Schall Law Firm

FUTU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:32 ET BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit with the Schall Law Firm

BMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:30 ET WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:28 ET AVAV Investors Have Opportunity to Lead AeroVironment, Inc. Securities Fraud Lawsuit with the Schall Law Firm

AVAV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:26 ET CALX Investors Have Opportunity to Lead Calix, Inc. Securities Fraud Lawsuit with the Schall Law Firm

CALX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:23 ET Sportradar Group AG Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SRAD

SRAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of

More news about: DJS Law Group LLP


Jun 29, 2026, 03:17 ET PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm

PHR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:15 ET IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm

IMMP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:13 ET GPK Investors Have Opportunity to Lead Graphic Packaging Holding Company Securities Fraud Lawsuit with the Schall Law Firm

GPK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:12 ET FSK Investors Have Opportunity to Lead FS KKR Capital Corp. Securities Fraud Lawsuit with the Schall Law Firm

FSK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:10 ET POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm

POET) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

In Study 1 and Study 2 Period B, participants originally randomized to upadacitinib dose groups in Period A will continue their same treatment in Period B for 28 weeks. Participants originally randomized to placebo in Period A will either remain on placebo in Period B, or be randomized in one of two

More news about: AbbVie


Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

In Study 1 and Study 2 Period B, participants originally randomized to upadacitinib dose groups in Period A will continue their same treatment in Period B for 28 weeks. Participants originally randomized to placebo in Period A will either remain on placebo in Period B, or be randomized in one of two

More news about: AbbVie


Jun 29, 2026, 03:09 ET SES Investors Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit with the Schall Law Firm

SES) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Jun 29, 2026, 03:00 ET Share buybacks in Ericsson during the period June 22 - June 26, 2026

the repurchases above, Ericsson's holding of treasury stock amounts to 63,998,958 Class B shares. There are in total 3,371,351,735 shares in Ericsson, 261,755,983 shares of Class A and 3,109,595,752 shares of Class B.NOTES TO EDITORS:FOLLOW US:

More news about: Ericsson


Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

for 48 weeks. Participants who completed Period A were eligible to enter Period B, a 112-week open-label extension in which all patients received upadacitinib 15 mg once daily. In total, Study 1 and Study 2 Periods A and B span 160 weeks. The two trials randomized 614 participants with NSV across 90 sites

More news about: AbbVie


Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

for 48 weeks. Participants who completed Period A were eligible to enter Period B, a 112-week open-label extension in which all patients received upadacitinib 15 mg once daily. In total, Study 1 and Study 2 Periods A and B span 160 weeks. The two trials randomized 614 participants with NSV across 90 sites

More news about: AbbVie


Jun 29, 2026, 02:55 ET Share buybacks in Ericsson during the period June 22 - June 26, 2026

the repurchases above, Ericsson's holding of treasury stock amounts to 63,998,958 Class B shares. There are in total 3,371,351,735 shares in Ericsson, 261,755,983 shares of Class A and 3,109,595,752 shares of Class B.NOTES TO EDITORS:FOLLOW US:

More news about: Ericsson


Jun 29, 2026, 02:31 ET 글로벌 축구 열풍: GAC, 세 개의 주요 파트너 클럽과 함께 영광을 향한 도전

multimedia:https://www.prnewswire.com/kr/news-releases/uAE00uB85CuBC8Cu002DuCD95uAD6Cu002DuC5F4uD48Du003Au002Du0067u0061u0063u002Cu002DuC138u002DuAC1CuC758u002DuC8FCuC694u002DuD30CuD2B8uB108u002D-302812947.htmlSOURCE

More news about: GAC


Jun 29, 2026, 02:00 ET Nichibei Kaiwa Gakuin Japanese Language Institute Receives MEXT Accreditation as Accredited Japanese Language Institution

Total enrolment capacity: 140 students- Approved Courses: Career Development One-Year Courses A-E and Career Development Two-Year Courses A, B (seven courses in total)- Accreditation number: 20252130074- MEXT announcement:

More news about: Nichibei Kaiwa Gakuin Japanese Language Institute


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.